Hansa Biopharma AB (HNSBF)
2.93
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Hansa Biopharma Net Income (TTM): -75.53M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -75.53M |
| March 31, 2024 | -79.94M |
| December 31, 2023 | -78.57M |
| September 30, 2023 | -80.77M |
| June 30, 2023 | -72.22M |
| March 31, 2023 | -65.69M |
| December 31, 2022 | -60.84M |
| September 30, 2022 | -65.43M |
| June 30, 2022 | -67.92M |
| March 31, 2022 | -66.31M |
| December 31, 2021 | -63.87M |
| September 30, 2021 | -57.67M |
| June 30, 2021 | -54.32M |
| March 31, 2021 | -48.81M |
| December 31, 2020 | -46.11M |
| September 30, 2020 | -45.35M |
| June 30, 2020 | -41.36M |
| March 31, 2020 | -39.82M |
| December 31, 2019 | -38.02M |
| September 30, 2019 | -35.45M |
| Date | Value |
|---|---|
| June 30, 2019 | -32.49M |
| March 31, 2019 | -30.55M |
| December 31, 2018 | -28.38M |
| September 30, 2018 | -25.29M |
| June 30, 2018 | -23.04M |
| March 31, 2018 | -21.37M |
| December 31, 2017 | -20.67M |
| September 30, 2017 | -18.50M |
| June 30, 2017 | -17.04M |
| March 31, 2017 | -15.65M |
| December 31, 2016 | -12.97M |
| September 30, 2016 | -11.51M |
| June 30, 2016 | -9.989M |
| March 31, 2016 | -8.926M |
| December 31, 2015 | -7.851M |
| September 30, 2015 | -7.322M |
| June 30, 2015 | -6.462M |
| March 31, 2015 | -4.525M |
| December 31, 2014 | -4.164M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-80.77M
Minimum
Sep 2023
-35.45M
Maximum
Sep 2019
-59.20M
Average
-62.36M
Median
Net Income (TTM) Benchmarks
| Abliva AB | -9.599M |
| Karolinska Development AB | -0.5424M |
| Calliditas Therapeutics AB | -45.52M |
| Oncopeptides AB | -24.46M |
| BioInvent International AB | -36.13M |